A case report of Gitelman syndrome resulting from two novel mutations in SLC12A3 gene
Wojciech Wolyniec, Sonia Kaniuka- Jakubowska, Mato Nagel and 5 more
Nefrología (English Edition) · 2016
doi:10.1016/j.nefroe.2015.09.004 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Introduction: Hypokalaemia is a common clinical problem. A potential but commonly overlooked cause of hypokalaemia is Gitelman syndrome. Material and methods: A 26-year-old man was admitted to the hospital due to syncope with general and muscular weakness and muscle cramps. The patient's history revealed previous recurrent syncope events associated to hypokalaemia with the lowest serum potassium value being 2.6 mmol/l. At admission, blood pressure was normal and no changes were found at physical examination. Laboratory tests showed mild hypokalaemia (3.0 mmol/l), hypomagnesaemia (1.36 mg/dl), hypocalciuria (< 40 mg/24 h), and metabolic alkalosis (HCO3− 29.7 mmol/l, BE 5.3 mmol/l). Results: Further laboratory tests (FeK, TTKG) confirmed inappropriate kaliuresis. Conn's disease was excluded by hormonal and imaging assessments. Genetic testing was performed and two novel heterozygous mutations: c.35_36insA and c.1095+5G>A were found in transcript NM_000339.2 in SLC12A3 gene. Conclusion: The patient was diagnosed with Gitelman syndrome and was treated with supplements of potassium and magnesium.
Abstract licence: CC BY-NC-ND
References23
- 22.
Gitelman syndrome · 2008
22 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.